In contrast, knockdown of USP8 promotes ASCL1 ubiquitination and its degradation in hBMSCs [54], indicating that USP8 inhibitors may play a candidate role in SCLC-A tumorigenesis. The gene discussed is ASCL1; the disease is small cell lung carcinoma.